FamiCord Services
for Business Partner

Bramble Bio

Bramble Bio, a Famicord company, provides services to support pharma, biotechs, hospitals and academics to develop manufacturing processes for their novel cell therapies and manufacture them for clinical and commercial use. Find out more here.

Process Development in Cell Therapy

Process development in cell therapy is about creating reliable and efficient ways to produce therapeutic cells. It involves figuring out how to grow, expand, and preserve the cells while ensuring they are safe, effective, and consistent. This process also focuses on making production scalable for larger use and meeting strict quality and safety standards required for medical treatments.

Manufacturing to cGMP

Manufacturing to cGMP (current Good Manufacturing Practices) means making products in a way that meets strict quality and safety standards set by regulators. It involves carefully controlling the environment, equipment, and processes to ensure consistency, purity, and safety. For cell therapy, this includes using cleanrooms, sterile techniques, and rigorous testing to ensure the cells are safe and effective for use in patients.

As a Contract Development and Manufacturing Organisation (CDMO), Bramble Bio has helped support tens of clinical trials and thousands of patients across a multitude of indications exclusively in human cell-based therapies.

FamiCord Services for Business Partner

Bramble Bio

Process Development in Cell Therapy

Manufacturing to cGMP

As a Contract Development and Manufacturing Organisation (CDMO), Bramble Bio has helped support tens of clinical trials and thousands of patients across a multitude of indications exclusively in human cell-based therapies.

FamiCord Services
for Business Partner